Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Structural basis of influenza virus neutralization.

Han T, Marasco WA.

Ann N Y Acad Sci. 2011 Jan;1217:178-90. doi: 10.1111/j.1749-6632.2010.05829.x. Epub 2011 Jan 11. Review.

2.

Power of yeast for analysis of eukaryotic translation initiation.

Altmann M, Linder P.

J Biol Chem. 2010 Oct 15;285(42):31907-12. doi: 10.1074/jbc.R110.144196. Epub 2010 Aug 6. Review. No abstract available.

3.

Cell surface display of highly pathogenic avian influenza virus hemagglutinin on the surface of Pichia pastoris cells using alpha-agglutinin for production of oral vaccines.

Wasilenko JL, Sarmento L, Spatz S, Pantin-Jackwood M.

Biotechnol Prog. 2010 Mar-Apr;26(2):542-7. doi: 10.1002/btpr.343.

PMID:
19950135
4.

Fine antigenic variation within H5N1 influenza virus hemagglutinin's antigenic sites defined by yeast cell surface display.

Li J, Wang Y, Liang Y, Ni B, Wan Y, Liao Z, Chan KH, Yuen KY, Fu X, Shang X, Wang S, Yi D, Guo B, Di B, Wang M, Che X, Wu Y.

Eur J Immunol. 2009 Dec;39(12):3498-510. doi: 10.1002/eji.200939532. Erratum in: Eur J Immunol. 2010 Mar;40(3):911. Chan, Kwok-hong [corrected to Chan, Kwok-hung].

5.

Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses.

Sui J, Hwang WC, Perez S, Wei G, Aird D, Chen LM, Santelli E, Stec B, Cadwell G, Ali M, Wan H, Murakami A, Yammanuru A, Han T, Cox NJ, Bankston LA, Donis RO, Liddington RC, Marasco WA.

Nat Struct Mol Biol. 2009 Mar;16(3):265-73. doi: 10.1038/nsmb.1566. Epub 2009 Feb 22.

6.

A decade of yeast surface display technology: where are we now?

Pepper LR, Cho YK, Boder ET, Shusta EV.

Comb Chem High Throughput Screen. 2008 Feb;11(2):127-34. Review.

7.

The cleavage of the hemagglutinin protein of H5N2 avian influenza virus in yeast.

Wang CY, Luo YL, Chen YT, Li SK, Lin CH, Hsieh YC, Liu HJ.

J Virol Methods. 2007 Dec;146(1-2):293-7. Epub 2007 Aug 28.

PMID:
17727967
8.

Scientific barriers to developing vaccines against avian influenza viruses.

Subbarao K, Joseph T.

Nat Rev Immunol. 2007 Apr;7(4):267-78. Review.

PMID:
17363960
9.

Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.

Levy R, Forsyth CM, LaPorte SL, Geren IN, Smith LA, Marks JD.

J Mol Biol. 2007 Jan 5;365(1):196-210. Epub 2006 Oct 3.

10.

Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus.

Oliphant T, Engle M, Nybakken GE, Doane C, Johnson S, Huang L, Gorlatov S, Mehlhop E, Marri A, Chung KM, Ebel GD, Kramer LD, Fremont DH, Diamond MS.

Nat Med. 2005 May;11(5):522-30. Epub 2005 Apr 24.

11.

Domain-level antibody epitope mapping through yeast surface display of epidermal growth factor receptor fragments.

Cochran JR, Kim YS, Olsen MJ, Bhandari R, Wittrup KD.

J Immunol Methods. 2004 Apr;287(1-2):147-58.

PMID:
15099763
12.

Supplemental Content

Support Center